Unlock ROI with segment and regional insights, competitive intelligence, growth opportunities, innovation trends, and actionable strategies for new revenue streams.Dublin, Oct. 05, 2026 (GLOBE ...
Researchers report that mitochondrial quality regulation gene activity defines two prognostically distinct breast cancer ...
A large Norwegian nested case-control study finds that the number of full-term pregnancies has essentially no effect on ...
The Global Bioinformatics Market was valued at USD 20.34 Billion in 2025 and is projected to expand at a 13.7% CAGR from 2026 ...
BACKGROUND: Epigenetic mechanisms underlying susceptibility to abdominal aortic aneurysm (AAA) remain poorly understood.
Intraoperative fluorescence imaging holds great promise for achieving complete cytoreduction in ovarian cancer, but its ...
Gene Testing, Bioinformatics and Precision Diagnostics Drive Clinical AdoptionDublin, Sept. 18, 2026 (GLOBE NEWSWIRE) -- "Pharmacogenomics Market Opportunity, Growth Drivers, Industry Trend Analysis, ...
The Global Bioinformatics Market was valued at USD 20.34 Billion in 2025 and is projected to expand at a 13.7% CAGR from 2026 to 2034, reaching USD 64.60 ...
Prioritize recurring consumables, AI analytics, FFPE-compatible automation and end-to-end workflows; target oncology, research institutes and CRO partnerships.Dublin, Oct. 08, 2026 (GLOBE NEWSWIRE) -- ...
Newly released 9th edition sizes the market at US$8.14 billion in 2025, with ctDNA leading and analysis of AI's impact. Profiles 117 companies including Guardant Health, Natera and Exact ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results